‘Other drugs are available’: Compounded semaglutide ban having no impact, claim telehealth corporates
Neither Eucalyptus nor Midnight Health expects the semaglutide compounding ban to affect its business.
Doctors at telehealth corporates have moved to Wegovy and Mounjaro as weight loss treatments ahead of today’s ban on semaglutide compounding.
The Federal Government announced back in May that it would ban pharmacists from compounding GLP-1 receptor agonists (RAs) from 1 October because of safety concerns.
It followed large-scale off-label prescribing at telehealth corporates, such as Eucalyptus, which runs online women’s health clinic Juniper; and the Nib-backed Midnight Health, which runs hub.health.
At the time, the government said 20,000 patients were being treated with off-label compounded semaglutide.
